GP-Act III Acquisition Corp. (NASDAQ:GPAT) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on October 26, 2026.
At publication ·
GP-Act III Acquisition Corp. (NASDAQ:GPAT) · proxy filed
At a glance
GP-Act III Acquisition Corp. (NASDAQ:GPAT) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on October 26, 2026.
The Financial Services company's proxy statement provides information for shareholders ahead of the annual meeting, including board nominations, executive compensation, and proposals for shareholder vote.
GP-Act III Acquisition Corp.'s stock currently trades at $11.04 with a market capitalization of $383.1M.
SEC filings provide mandatory disclosures that give investors access to the same material information available to institutional investors. Reviewing GP-Act III Acquisition Corp.'s filings alongside price action and analyst commentary provides a more complete picture of the company's current situation.
All SEC filings for GP-Act III Acquisition Corp. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View GPAT Stock Page
Browse all filings on our GPAT SEC filings page.
Public companies like GP-Act III Acquisition Corp. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
Current market data
NASDAQ · GPAT
$11.10
Down: -$0.02 · -0.18%
Live quote updated
